ACST Stock Price History and Quote Analysis: Insights for Investors
Acasti Pharma Inc.
Stock Price Today
Acasti Pharma Inc. (ACST) stock declined over -3.60%, trading at $2.68 on NASDAQ, down from the previous close of $2.78. The stock opened at $2.79, fluctuating between $2.65 and $2.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Company Information
| Employees | 32 |
| Beta | 1.515 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | March |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Acasti Pharma Inc. (NASDAQ: ACST) stock price is $2.68 in the last trading session. During the trading session, ACST stock reached the peak price of $2.80 while $2.65 was the lowest point it dropped to. The percentage change in ACST stock occurred in the recent session was -3.6% while the dollar amount for the price change in ACST stock was -$0.10.
The NASDAQ listed ACST is part of Biotechnology industry that operates in the broader Healthcare sector. Acasti Pharma Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. George Kottayil
Chief Operating Officer of US
Ms. Carrie D'Andrea
Vice President of Clinical Operations
Ms. Janelle D'Alvise
Pres, Chief Executive Officer, Corporation Sec. & Director
Dr. Yves Lachance Ph.D.
Vice President of Quality & Compliance
Dr. Pierre Lemieux M.D., Ph.D.
Co-Founder, Chief Operating Officer & Chief Scientific Officer
Carrie D'Andrea
Vice President of Clinical Operations
Ms. Christine Pelletier
Senior Director of HR
Ms. Christine Pelletier CHRP
Senior Director of HR
Mr. Amresh Kumar Ph.D.
Vice President of Program Management
Dr. R. Loch MacDonald M.D., Ph.D.
Member of Scientific Advisory Board & Chief Medical Officer
Mr. Prashant Kohli
Chief Executive Officer
Mr. Brian D. Ford CPA, CA
Interim Chief Financial Officer
ACST's closing price is 61.63% higher than its 52-week low of $1.72 where as its distance from 52-week high of $3.59 is -22.56%.
Number of ACST employees currently stands at 32.
Official Website of ACST is: https://www.acastipharma.com
ACST could be contacted at phone 450 687 2262 and can also be accessed through its website. ACST operates from 3009 boulevard de la Concorde East, Laval, QC H7E 2B5, Canada.
ACST stock volume for the day was 40.91K shares. The average number of ACST shares traded daily for last 3 months was 15.12K.
The market value of ACST currently stands at $27.17M with its latest stock price at $2.68 and 10.14M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com